Neurogranin, a postsynaptic marker involved in spatial memory, is consistently elevated in CSF in AD cases compared to controls [126–128] and has been linked to accelerated cognitive decline and hippocampal atrophy [129]. Here, NRGN is linked to Alzheimer disease.